Viral infections:

Indications for: XOFLUZA

Treatment of acute uncomplicated influenza in patients who have been symptomatic for no more than 48hrs and who are otherwise healthy, or at high risk of developing influenza-related complications. Post-exposure prophylaxis of influenza following contact with an individual who has influenza.

Limitations of Use:

Consider available information on drug susceptibility patterns for circulating influenza strains when deciding whether to use.

Adult Dosage:

Start within 48hrs of symptom onset or exposure to influenza. ≥12yrs (<80kg): 40mg as a single dose; (≥80kg): 80mg as a single dose.

Children Dosage:

<12yrs: not established.

XOFLUZA Warnings/Precautions:

Potential secondary bacterial infections; treat appropriately. Pregnancy. Nursing mothers.

XOFLUZA Classification:

Polymerase acidic (PA) endonuclease inhibitor.

XOFLUZA Interactions:

Avoid co-administration with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (eg, calcium, iron, magnesium, selenium, or zinc). May reduce efficacy of live attenuated influenza vaccines.

Adverse Reactions:

Diarrhea, bronchitis, nausea, sinusitis, headache; hypersensitivity reactions.

Generic Drug Availability:

NO

How Supplied:

Tabs—2

Pricing for XOFLUZA

2 tablets of 40mg dose pack (Qty: 1)
Appx. price $166
GoodRx